Risk Factors for Relapse in ANCA-Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab

RDCRN https://pubmed.ncbi.nlm.nih.gov/41412975/ 2025-12-18T00:00:00Z Arthritis & Rheumatology